Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000690739 | SCV000818440 | likely benign | Spastic paraplegia | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002547157 | SCV003631590 | uncertain significance | Inborn genetic diseases | 2022-07-08 | criteria provided, single submitter | clinical testing | The c.7100C>T (p.A2367V) alteration is located in exon 10 (coding exon 9) of the SACS gene. This alteration results from a C to T substitution at nucleotide position 7100, causing the alanine (A) at amino acid position 2367 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001275189 | SCV001460047 | uncertain significance | Charlevoix-Saguenay spastic ataxia | 2020-01-17 | no assertion criteria provided | clinical testing |